Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

Xenon Pharmaceuticals to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference


BURNABY, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer, will present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference in Toronto, Canada on Wednesday, May 2, 2018 at 9:30 am ET.

A live audio webcast of the presentation will be available on the investors section of Xenon's website at www.xenon-pharma.com and will be available for replay following the event.

About the Bloom Burton & Co. Healthcare Investor Conference
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian, and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies.

About Xenon Pharmaceuticals Inc.

Xenon is a clinical stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Building upon our extensive knowledge of human genetics and diseases caused by mutations in ion channels, known as channelopathies, we are advancing ? both independently and with our pharmaceutical collaborators ? a novel product pipeline of ion channel modulators to address therapeutic areas of high unmet medical need, such as pain and epilepsy. For more information, please visit www.xenon-pharma.com.

"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Vice President, Corporate Affairs & Investor Relations
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: [email protected]


These press releases may also interest you

at 14:55
According to Arizton's latest focus insight report, the US laboratory developed tests market is growing at a CAGR of 3.40% from 2023 to 2029....

at 14:45
The International Society for Pharmaceutical Engineering (ISPE) has announced featured speakers and a focus on digital innovation for the 2024 ISPE Biotechnology Conference. The focus on integrating new technologies and pioneering strategies aligns...

at 14:29
iHealth Labs, Inc. (iHealth®), a leading provider of digital health solutions, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's 3-in-1 COVID-19/Flu A&B Rapid Test Kit...

at 14:15
The CDC now estimates nearly half a million people will contract Lyme disease in the United States each year. However, most people do not realize how Lyme disease can cause diverse, devastating symptoms in some patients. The range of symptoms is...

at 14:15
Frederick, MD-based Genesis + HOCL introduces two HOCl atomizing machines for Air Quality Awareness Week. Genesis is the sole U.S. distributor of this technology, previously only available in Japan and South Korea, bringing the Genesis 2.6 and UX4 to...

at 14:09
The Independence Fund proudly presents "Beyond the Call" luncheon, a fundraising event dedicated to honoring and supporting the Caregivers of our nation's wounded Veterans. Join the event on May 16, 2024, at 11:00 AM at the Duke Mansion in Charlotte,...



News published on and distributed by: